Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Jaco Voorham, Bernard Vrijens, Job FM van Boven, Dermot Ryan, Marc Miravitlles, Lisa M Law & David B Price. (2017) Does co-payment for inhaler devices affect therapy adherence and disease outcomes? A historical, matched cohort study. Pragmatic and Observational Research 8, pages 31-41.
Read now
Read now
Zoltán Kaló, Ibrahim Alabbadi, Ola Ghaleb Al Ahdab, Maryam Alowayesh, Mahmoud Elmahdawy, Abdulaziz H Al-Saggabi, Vito Luigi Tanzi, Daoud Al-Badriyeh, Hamad S Alsultan, Faleh Mohamed Hussain Ali, Gihan H Elsisi, Kasem S Akhras, Zoltán Vokó & Panos Kanavos. (2015) Implications of external price referencing of pharmaceuticals in Middle East countries. Expert Review of Pharmacoeconomics & Outcomes Research 15:6, pages 993-998.
Read now
Read now
Cara Usher & Michael Barry. (2012) A reference pricing system for Ireland. Expert Review of Pharmacoeconomics & Outcomes Research 12:6, pages 675-677.
Read now
Read now
Kristina Garuoliene, Brian Godman, Jolanta Gulbinovič, Björn Wettermark & Alan Haycox. (2011) European countries with small populations can obtain low prices for drugs: Lithuania as a case history. Expert Review of Pharmacoeconomics & Outcomes Research 11:3, pages 343-349.
Read now
Read now
Brian Godman, William Shrank, Morten Andersen, Christian Berg, Iain Bishop, Thomas Burkhardt, Kristina Garuoliene, Harald Herholz, Roberta Joppi, Marija Kalaba, Ott Laius, Diane McGinn, Vita Samaluk, Catherine Sermet, Ulrich Schwabe, Inês Teixeira, Lesley Tilson, F Cankat Tulunay, Vera Vlahović-Palčevski, Kamila Wendykowska, Björn Wettermark, Corinne Zara & Lars L Gustafsson. (2010) Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications. Expert Review of Pharmacoeconomics & Outcomes Research 10:6, pages 707-722.
Read now
Read now
Lesley Tilson & Michael Barry. (2010) Recent developments in pharmacoeconomic evaluation in Ireland. Expert Review of Pharmacoeconomics & Outcomes Research 10:3, pages 221-224.
Read now
Read now
Articles from other publishers (20)
Sean D SullivanKiera D SullivanOmar DabbousLouis P Garrison. (2022) International reference pricing of pharmaceuticals in the United States: Implications for potentially curative treatments. Journal of Managed Care & Specialty Pharmacy 28:5, pages 566-572.
Crossref
Crossref
Gretta Mohan & Anne Nolan. (2019) The impact of prescription drug co-payments for publicly insured families. The European Journal of Health Economics 21:2, pages 261-274.
Crossref
Crossref
Amanda Hanora Lavan, Denis O’Mahony & Paul Gallagher. (2019) STOPPFrail (Screening Tool of Older Persons’ Prescriptions in Frail adults with a limited life expectancy) criteria: application to a representative population awaiting long-term nursing care. European Journal of Clinical Pharmacology 75:5, pages 723-731.
Crossref
Crossref
Paul Dillon, Susan M. Smith, Paul Gallagher & Gráinne Cousins. (2018) Impact of financial burden, resulting from prescription co-payments, on antihypertensive medication adherence in an older publically insured population. BMC Public Health 18:1.
Crossref
Crossref
Soraya Nouraei Motlagh, Mohammad Hadian, Abdoreza Mousavi, Samira Alipour, Reza Jahangiri & Moharam Ali Rostami. (2018) Investigating the Effects of Exchange Rate Fluctuations on the Import and Export of Medicine in Iran from 2001 to 2014. Shiraz E-Medical Journal 19:10.
Crossref
Crossref
Laura McCullagh & Michael Barry. (2016) The Pharmacoeconomic Evaluation Process in Ireland. PharmacoEconomics 34:12, pages 1267-1276.
Crossref
Crossref
Sarah-Jo Sinnott, Charles Normand, Stephen Byrne, Noel Woods & Helen Whelton. (2016) Copayments for prescription medicines on a public health insurance scheme in Ireland. Pharmacoepidemiology and Drug Safety 25:6, pages 695-704.
Crossref
Crossref
Amanda Lavan, Paul Gallagher & Denis O’Mahony. 2016. Developing Drug Products in an Aging Society. Developing Drug Products in an Aging Society
737
757
.
Brian P. Reddy, Roisin Adams, Cathal Walsh, Michael Barry & Paul Kind. (2015) Using the Analytic Hierarchy Process to Derive Health State Utilities from Ordinal Preference Data. Value in Health 18:6, pages 841-845.
Crossref
Crossref
Aisling Conway, Martin Kenneally, Noel Woods, Andreas Thummel & Marie Ryan. (2014) The implications of regional and national demographic projections for future GMS costs in Ireland through to 2026. BMC Health Services Research 14:1.
Crossref
Crossref
Conor Lahiff, Seán Cournane, Donnacha Creagh, Brian Fitzgerald, Richard Conway, Declan Byrne & Bernard Silke. (2014) Factors predicting the hospital episode costs of emergency medical admissions. European Journal of Internal Medicine 25:7, pages 633-638.
Crossref
Crossref
E. Ankrah Odame, P. Akweongo, B. Yankah, F. Asenso-Boadi & I. Agyepong. (2013) Sustainability of recurrent expenditure on public social welfare programmes: expenditure analysis of the free maternal care programme of the Ghana National Health Insurance Scheme. Health Policy and Planning 29:3, pages 271-279.
Crossref
Crossref
Akke Vellinga, Sarah Cormican, Jacqueline Driscoll, Michelle Furey, Mai O'Sullivan & Martin Cormican. (2014) Public practice regarding disposal of unused medicines in Ireland. Science of The Total Environment 478, pages 98-102.
Crossref
Crossref
Lianne Barnieh, Fiona Clement, Anthony Harris, Marja Blom, Cam Donaldson, Scott Klarenbach, Don Husereau, Diane Lorenzetti & Braden Manns. (2014) A Systematic Review of Cost-Sharing Strategies Used within Publicly-Funded Drug Plans in Member Countries of the Organisation for Economic Co-Operation and Development. PLoS ONE 9:3, pages e90434.
Crossref
Crossref
Adam D.M. Briggs. (2013) How changes to Irish healthcare financing are affecting universal health coverage. Health Policy 113:1-2, pages 45-49.
Crossref
Crossref
M. Gleeson, P. Coyle, M. Clarke Moloney, S. R. Walsh & P. A. Grace. (2013) An audit of generic prescribing in a general surgical department. Irish Journal of Medical Science 182:3, pages 403-408.
Crossref
Crossref
Aoife Brick, Paul K Gorecki & Anne Nolan. (2013) Usage of generics in Ireland: Recent trends and policy developments. Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector 10:2, pages 72-85.
Crossref
Crossref
Sarah-Jo Sinnott, Claire Buckley, David O′Riordan, Colin Bradley & Helen Whelton. (2013) The Effect of Copayments for Prescriptions on Adherence to Prescription Medicines in Publicly Insured Populations; A Systematic Review and Meta-Analysis. PLoS ONE 8:5, pages e64914.
Crossref
Crossref
Martin Kenneally & Valerie Walshe. (2012) Pharmaceutical Cost-Containment Policies and Sustainability: Recent Irish Experience. Value in Health 15:2, pages 389-393.
Crossref
Crossref
L. Tilson, M. Jit, S. Schmitz, C. Walsh, P. Garvey, P. McKeown & M. Barry. (2011) Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland. Vaccine 29:43, pages 7463-7473.
Crossref
Crossref